Logo Logo
Switch Language to German

Gattermann, Norbert; Hofmann, Wolf-Karsten; Meeßen, Axel; Schmitz, Stephan; Tsamaloukas, Anton; Vollmer, Tanja; Wedding, Ulrich; Plesnila-Frank, Carlotta; Schramm, Wolfgang and Berger, Karin (2008): Myelodysplastic syndromes: Aspects of current medical care and economic considerations in Germany. In: Onkologie, No. 8-9: pp. 477-484 [PDF, 110kB]


Myelodysplastic syndromes (MDS) are a heterogeneous group of diseases mainly affecting older people. The use of an increasing number of therapeutic options depends on a systematic risk stratification of the patients. A high percentage of MDS patients need blood transfusions as supportive care, which influence quality of life and cause a great part of the costs generated by MDS therapy. In this article which is based on a workshop about the burden of MDS held in October 2006 in Munich, MDS is discussed with regard to different aspects: current therapies, transfusion medicine, geriatrics, quality of life, and health economic aspects.

Actions (login required)

View Item View Item